Ziyang East, listed 650 million

robot
Abstract generation in progress

Speculative trading involves high risks; do not follow blindly [Taogu Ba]

Ziyang East Road: Invested 230 million in Hongbao l, 140 million in Luxhua Technology j (3 days), 130 million in Chuanjin n, 110 million in Zhengzhou Coal d (3 days), sold 250 million in Han Cable f

Ge L Da: Invested 110 million in Hengdian East c

North First Ring: Invested 130 million in Tongyu Heavy g, sold in Baichuan Stock f, added to Baicai c

Zhang Meng z: Invested 71 million in Chitian h, 43 million in Luxhua Technology j

Ningbo Sandian Road: Invested 42 million in Zhengzhou Coal d

Yangjia: Invested 16 million in Zhonghong Medical l, 14 million in Southern Road j, sold Hengtong Stock f

Zhongshan East Road: Invested 14 million in Luxhua Technology j

Maker Mou Yi: Sold 360 million in Guangxun Technology j, sold in Baichuan Stock f, Shuangyi Technology j

Institutional Seats:

2 institutions invested 700 million in Baofeng Neng y, 3 institutions sold 510 million in Guangxun Technology j

Brief Analysis:

  1. Today’s Dragon and Tiger List activity significantly declined, with fewer stocks on the list. Only Ziyang East Road, Ge L Da, and North First Ring had single stocks exceeding 100 million. Zhang Mengzhu and Sandian Road were relatively active, with large new sell-offs.

  2. Highlights today: Ziyang East and Zhang Mengzhu mainly involved in chemical sectors; Ge L Da involved in magnetic materials; North First Ring involved in nuclear energy.

  3. The Dragon and Tiger List includes quite luxurious stocks like Hongbao l and Hengdian East c.

  4. From the perspective of Kai Pan La software statistics: the listed seats are incomplete; some 3-day list software calculates net purchases incorrectly. Therefore, manual statistics are more accurate. This is for reference only.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin